CONTENTS DiePharmazie 6/2010 Reviews Bodor N, Buchwald P: Recent advances in
retrometabolic drug design (RMDD) and development Loftsson T: Aqueous solubility and true solutions
Original articles Hidvégi E, Somogyi GP: Detection of cannabigerol
and its presumptive metabolite in human urine after Cannabis consumption Wu WM, Tang Y, Buchwald P, Bodor N:
Pharmacokinetics and cortienic acid excretion after intravenous administration of
prednisolone and loteprednol etabonate in rats Wu B, Derendorf H: Pharmacokinetic/pharmacodynamic
model-based combination therapy approach to target antibiotic resistant populations
emerged from ciprofloxacin exposure Buchwald P, Bocca N, Marzorati S, Hochhaus G, Bodor N,
Stabler C, Kenyon NS, Inverardi L, Molano RD, Ricordi C, Pileggi A: Feasibility
of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid
device designed for cell transplantation Pinto E, Zhang B, Song S, Bodor N, Buchwald P, Hochhaus G:
Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local
delivery of a soft immunosuppressant Berta E, Samson L, Lenkey A. Erdei A, Cseke B, Jenei K,
Major T, Jakab A, Jenei Z, Paragh G, Nagy EV, Bodor M: Evaluation of the thyroid
function of healthy pregnant women by five different hormone assays Murakami T, Yokooji T, Mori N: Study on absorption
sites of quinidine and methotrexate in rat intestine All research papers in thes issue were presented during the 7th Conference on Retrometabolism Based Drug Design and Targeting, May 10-13, 2010, Orlando, Florida, U. S. A.
|
